Suppr超能文献

在神经病理性疼痛大鼠模型中,联合应用奈福泮、吗啡和尼美舒利增强镇痛作用。

Enhancement of Antinociception by Co-administrations of Nefopam, Morphine, and Nimesulide in a Rat Model of Neuropathic Pain.

机构信息

Department of Pharmacology & Neuroscience Research Center, Shahid Beheshti Medical University, Tehran, Iran.

出版信息

Korean J Pain. 2012 Jan;25(1):7-15. doi: 10.3344/kjp.2012.25.1.7. Epub 2012 Jan 2.

Abstract

BACKGROUND

Neuropathic pain is a chronic pain due to disorder in the peripheral or central nervous system with different pathophysiological mechanisms. Current treatments are not effective. Analgesic drugs combined can reduce pain intensity and side effects. Here, we studied the analgesic effect of nimesulide, nefopam, and morphine with different mechanisms of action alone and in combination with other drugs in chronic constriction injury (CCI) model of neuropathic pain.

METHODS

Male Wistar rats (n = 8) weighing 150-200 g were divided into 3 different groups: 1- Saline-treated CCI group, 2- Saline-treated sham group, and 3- Drug-treated CCI groups. Nimesulide (1.25, 2.5, and 5 mg/kg), nefopam (10, 20, and 30 mg/kg), and morphine (1, 3, and 5 mg/kg) were injected 30 minutes before surgery and continued daily to day 14 post-ligation. In the combination strategy, a nonanalgesic dose of drugs was used in combination such as nefopam + morphine, nefopam + nimesulide, and nimesulide + morphine. Von Frey filaments for mechanical allodynia and acetone test for cold allodynia were, respectively, used as pain behavioral tests. Experiments were performed on day 0 (before surgery) and days 1, 3, 5, 7, 10, and 14 post injury.

RESULTS

Nefopam (30 mg/kg) and nimesulide (5 mg/kg) blocked mechanical and thermal allodynia; the analgesic effects of morphine (5 mg/kg) lasted for 7 days. Allodynia was completely inhibited in combination with nonanalgesic doses of nefopam (10 mg/kg), nimesulide (1.25 mg/kg), and morphine (3 mg/kg).

CONCLUSIONS

It seems that analgesic drugs used in combination, could effectively reduce pain behavior with reduced adverse effects.

摘要

背景

神经病理性疼痛是一种由于外周或中枢神经系统紊乱引起的慢性疼痛,具有不同的病理生理机制。目前的治疗方法并不有效。联合使用镇痛药物可以降低疼痛强度和副作用。在这里,我们研究了具有不同作用机制的尼美舒利、奈福泮和吗啡单独使用以及与其他药物联合使用在慢性缩窄性损伤(CCI)神经病理性疼痛模型中的镇痛效果。

方法

雄性 Wistar 大鼠(n = 8)体重 150-200 g 分为 3 组:1-盐水处理的 CCI 组,2-盐水处理的假手术组,和 3-药物处理的 CCI 组。尼美舒利(1.25、2.5 和 5 mg/kg)、奈福泮(10、20 和 30 mg/kg)和吗啡(1、3 和 5 mg/kg)在手术前 30 分钟注射,并持续至结扎后 14 天。在联合策略中,使用非镇痛剂量的药物联合使用,如奈福泮+吗啡、奈福泮+尼美舒利和尼美舒利+吗啡。Von Frey 纤维用于机械性痛觉过敏,丙酮测试用于冷感觉过敏,分别作为疼痛行为测试。实验分别于第 0 天(手术前)和第 1、3、5、7、10 和 14 天进行。

结果

奈福泮(30 mg/kg)和尼美舒利(5 mg/kg)阻断机械性和热感觉过敏;吗啡(5 mg/kg)的镇痛作用持续 7 天。非镇痛剂量的奈福泮(10 mg/kg)、尼美舒利(1.25 mg/kg)和吗啡(3 mg/kg)联合使用可完全抑制痛觉过敏。

结论

联合使用镇痛药物似乎可以有效减轻疼痛行为,同时减少不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69dd/3259142/5f574e1fafa2/kjpain-25-7-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验